Evidence map›Paper›PMID 37330508›Full record

ArticleRadiation oncology (London, England)2023

Advantages and robustness of partial VMAT with prone position for neoadjuvant rectal cancer evaluated by CBCT-based offline adaptive radiotherapy.

Zhe Zhang, Shou Yu, Feng Peng, Zhibo Tan, Lei Zhang, Daming Li, Pengfei Yang, Zhaoming Peng, Xin Li, Chunfeng Fang and 2 more

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhe ZhangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Shou YuDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Feng PengDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Zhibo TanDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Lei ZhangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Daming LiDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Pengfei YangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Zhaoming PengDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Xin LiDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Chunfeng FangDepartment of Radiation Oncology, Hebei Yizhou Cancer Hospital, Zhuozhou, China.
Yuenan WangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China. yuenan.wang@gmail.com.
Yajie LiuDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen, China. Anthea1966@163.com.

Funding

CAS Key Laboratory of Health Informatics, Shenzhen Institute of Advanced Technology 2011DP173015Sanming Project of Medicine in Shenzhen SZSM201612041Science, Technology and Innovation Commission of Shenzhen Municipality GJHZ20200731095207023
6 · The paper itself

Abstract

background and purposeThis study aims to explore the advantages and robustness of the partial arc combined with prone position planning technique for radiotherapy in rectal cancer patients. Adaptive radiotherapy is recalculated and accumulated on the synthesis CT (sCT) obtained by deformable image registration between planning CT and cone beam CT (CBCT). Full and partial volume modulation arc therapy (VMAT) with the prone position on gastrointestinal and urogenital toxicity, based on the probability of normal tissue complications (NTCP) model in rectal cancer patients were evaluated. MATERIALS AND

methodsThirty-one patients were studied retrospectively. The contours of different structures were outlined in 155 CBCT images. First, full VMAT (F-VMAT) and partial VMAT (P-VMAT) planning techniques were designed and calculated using the same optimization constraints for each individual patient. The Acuros XB (AXB) algorithm was used in order to generate more realistic dose distributions and DVH, considering the air cavities. Second, the Velocity 4.0 software was used to fuse the planning CT and CBCT to obtain the sCT. Then, the AXB algorithm was used in the Eclipse 15.6 software to conduct re-calculation based on the sCT to obtain the corresponding dose. Furthermore, the NTCP model was used to analyze its radiobiological side effects on the bladder and the bowel bag.

resultsWith a CTV coverage of 98%, when compared with F-VMAT, P-VMAT with the prone position technique can effectively reduce the mean dose of the bladder and the bowel bag. The NTCP model showed that the P-VMAT combined with the prone planning technique resulted in a significantly lower complication probability of the bladder (1.88 ± 2.08 vs 1.62 ± 1.41, P = 0.041) and the bowel bag (1.28 ± 1.70 vs 0.95 ± 1.52, P < 0.001) than the F-VMAT. In terms of robustness, P-VMAT was more robust than F-VMAT, considering that less dose and NTCP variation was observed in the CTV, bladder and bowel bag.

conclusionThis study analyzed the advantages and robustness of the P-VMAT in the prone position from three aspects, based on the sCT fused by CBCT. Whether it is in regards to dosimetry, radiobiological effects or robustness, P-VMAT in the prone position has shown comparative advantages.

Indexed as

Radiotherapy, Intensity-ModulatedRectal NeoplasmsSpiral Cone-Beam Computed TomographyHumansNeoadjuvant TherapyProne PositionRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRetrospective StudiesNeoadjuvant rectal cancerOffline ARTPartial VMATProne position

Identifiers

PMID37330508
PMCPMC10276517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.